GENE ONLINE|News &
Opinion
Blog

IPO
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
Oxford Nanopore Soars on London Market Debut
2021-10-05
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
Singapore Exchange to Allow SPAC Listings on the Mainboard
2021-09-03
Revelation Goes the SPAC Way to list on Nasdaq
2021-08-31
Clarity Becomes ASX’s Biggest Ever Biotech IPO
2021-08-30
With Increasing Appeal for RNA Technology, Medford Startup Jumps on the SPAC Wagon to Go Public
2021-08-10
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
What are Investors Looking for in a Biotech Startup?
2021-07-27
Could this Biotech be the First Billion-Dollar Hong Kong Startup to Go Public?
2021-07-18
China’s Brii Bio Raises $319 million in the Hong Kong IPO
2021-07-16
Chinese Oncology Drugmaker to Raise over 600 Million in Hong Kong IPO
2021-06-22
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
1 2 3 4
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!